MMU Research and Knowledge Exchange Blog

Funding opportunities, news and guidance from RKE at Manchester Met


Leave a comment

Pre-call announcement: UK-Japan Regenerative Medicine and Stem Cell Research Initiative

The MRC and the Japan Agency for Medical Research and Development (AMED) are pleased to announce they will soon be launching a joint call for research proposals focused on Regenerative Medicine and Stem Cell Research.

This initiative will support collaborative (UK-Japanese) research projects that build upon fundamental insights and initial early-stage discoveries, to advance regenerative approaches towards clinical use in the future and to utilise stem cells as medial research tools.

Applications will be particularly welcome for projects focusing on:

  • Human cell engineering, gene editing and cellular reprogramming approaches where a clear future therapeutic goal has been identified.
  • Investigations into modulation of the human tissue niche, or improving understanding of the niche; this may include for example establishing mechanisms for differentiation in transplanted stem cells or understanding immunological barriers.
  • Improving efficacy of engraftment and regeneration of transplanted cells.
  • Developing tools, technologies and methods to enable translational regenerative medicine research including, but not limited to, in-vivo cell imagining approaches or high throughput screening techniques.
  • Creating novel on-vitro models utilising stem cells which could be used for robust predictive safety testing or as drug screening models.

Alternative project outcomes such as therapeutic candidates, medical devices and diagnostic agents mat also be supported by this call.

MRC will make up to £5m available to support the UK component of the collaborative research projects. It is expected that the available funds will support approximately 8 projects/

For further details and updates please visit the MRC and AMED websites in December.


Leave a comment

Myotubular Trust – Call for Projects

The Myotubular Trust is a registered charity that was set up to find a cure and treatments for any genetic form of centronuclear and myotubular myopathy.

The trust has launched a call for projects that will help to find a cure or treatment of any form of centronuclear and myotubular myopathy. They will be focusing on research that would generally not be funded by public or industrial funding sources.

Duration: 2 – 3 years (Project Grant), 3-4 years (Fellowship)

Deadline: Friday 15th March – 5pm

Applications are particularly encouraged investigating new technologies to research into centronuclear and myotubular myopathy; interventional trials; and those which may involve collaboration between different medical disciplines and/or different research institutions.

For further information please visit the Myotubular Trust Website.

If you would like to apply for this scheme please contact your research development team.


Leave a comment

Latest Opportunities from NIHR

Funding

Health Technology Assessment Programme (HTA):

19/07 Anti-TB Drug Hepatotoxicity and Treatment Reintroduction

Programme Development Grants

Competition 24

Programme Grants for Applied Research

Competition 29

Public Health Research Programme

19/01 Improving Health and Wellbeing for People who are at Risk of or Exposed to Adverse Childhood Experiences (ACEs)

19/02 Interventions that Reduce Harmful Substance Use With a Focus on Novel Psychoactive Substances

19/03 Systems Approaches to Local Influences on Food Choices and Diet

19/04 Community Focused Approaches That Mobilise People as Assets

Joint NIHR and Medical Research Council Opportunity

Global Maternal and Neonatal Health 2019 – Outlines.


Leave a comment

Research & Innovation in the NHS Long Term Plan

Last week the NHS released their long term plan with funding of £20.5 billion backing the new plans up to 2023, of course research and innovation features within the plan which is summarised below.


Research and innovation are key to both the NHS and UK economy. ‘Research-active’ hospitals have lower mortality rates with patients benefiting from earlier diagnosis, more effective treatments and faster recovery. The government plans to treble it’s industry contract and R&D collaborative research with the NHS over the next ten years to nearly £1 billion.

The NHS will be working to increase the number of people registered to participate in health research to 1 million by 2023/24, one way of doing this will be by allowing people to register their interest via an app by 2020.

There is a particular focus on investing in genomics research with the aim to be the first national health care system to offer whole genome sequencing as part of routine care. During 2019 seriously ill children who are likely to have rare genetic disorders, children with cancer, and adults suffering from certain rare conditions or specific cancers, will begin to be offered whole genome sequencing.

Uptake of proven, affordable innovations will be accelerated through a new Medtech funding mandate. This applies to health tech products (other than pharmaceuticals) assessed as cost saving by NICE. The number of NICE evaluations will also be significantly increased giving greater scope for assessment of digital products in particular.


For more information about the NHS long term plan you can visit the plans here.


Leave a comment

Wellcome – New Areas in Development

The Wellcome Trust are exploring two new areas in development to investigate what impact their involvement could have and decide whether these should be taken forward as new priority areas.

Data for Science and Health

What can Wellcome do to drive innovative and imaginative uses of data to improve science and health? They’ll be looking to transform three key areas:

  • Access to data. They wish to improve access e.g. by helping to make datasets more interoperable, or simplifying complex regulatory frameworks. Researchers can access the data they need for their research.
  • Diversity of the Workforce. Datascience does not have adiverse workforce, this could be due to researchers with different skillsets not having the opportunity to collaborate.
  • Public confidence in data use. Nuilding up public trust around new uses of data so that everyone can benefit.

Snakebites

Snakebites are one of the most neglected health problems in low and middle income countries, between 80,000 and 140,000 people die each year from being bitten by venomous snakes with 400,000 left with life changing disabilities. Wellcome will be investigating:

  • Reviving and stabilising the market for effective antivenoms.
  • Accelerating research and innovation to improve existing antivenoms and develop alternatives.
  • Working with funders, researchers and policymakers and industry.

More details will follow about the programmes of work – keep an eye on the Wellcome Trust website for more details.


Leave a comment

Europe: Festive Funding Opportunities

 

In a pre-Christmas flurry, a few opportunities have been announced which may be of interest to readers:

  • Innovative Medicine Initiative (IMI) – IMI has announced its tenth call for proposals supporting research in a variety of areas including hypoglycaemia; use of big data in diagnosis and treatment of prostate cancer; improving care for patients suffering from acute or chronic pain; patient perspectives in medicines lifecycle; and personalised medicine in autism spectrum disorders. Deadline for stage one proposals is 28 March 2017 and details can be found here.
  • SESAR – has announced their new call for proposals on research focused on optimising Air Traffic Management (ATM) performance and intelligent air transport. The deadline for full proposals is 22 March 2017 and details on topics supported and conditions can be found here.
  • QuantERA – QuantERA is a new initiative which will support research in the field of quantum technologies, with the UK’s involvement supported by EPSRC. In a recently published pre-announcement, QuantERA have flagged that they will launch a call for proposals in January, with a likely deadline for stage one proposals of 15 March 2017.

In other news, those of you with Swiss partners will be interested to hear that Switzerland and the EC have successfully completed negotiations which will grant Switzerland the status of an Associated Country within Horizon 2020. This allows Swiss organisations to participate in Horizon 2020 on an even footing with EU Member States.

As ever, if you are thinking of applying, or would like more information about any of the enclosed do get in touch (euro_res@mmu.ac.uk)!


Leave a comment

Grab a Grant

It’s been a while, but take a look at these research related funding opportunities. Please pass on to any colleagues you feel may also be interested.

Institute of Physics and Engineering in Medicine Innovation Grant

These support short term innovation and research projects in the application of physics and engineering to medicine and biology, including healthcare practice, medical device design, research and teaching.

Value: £10,000
Deadline: 31 July

Institution of Civil Engineers QUEST travel award

This enables civil engineer professionals and graduates to travel overseas and undertake an activity that benefits both their professional development and the surrounding community.

Value: £1,500 for individuals, or £6,000 for a group
Deadline: 30 Aug

National Eye Research Centre Small Project Grants

These support small research projects related to the causes and treatment of eye disease and blindness.

Value: £10,000
Deadline: no deadline

For support with your application, please contact Research Development.